LDN Research Trust

Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients

Hum Psychopharmacol
24 May 2021
https://pubmed.ncbi.nlm.nih.gov/34029405/

Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and Beta-Endorphin

eNeuro
24 May 2021
https://www.eneuro.org/content/early/2021/05/21/ENEURO.0087-21.2021

Addiction Medication Promising for Chronic, Refractory Pain

Medscape Medical News
01 May 2021
https://www.medscape.com/viewarticle/950263

Preliminary data from a retrospective chart review of patients with chronic pain showed those who received LDN experienced significant improvement in both pain and disability.

The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia

Front Psychiatry
16 February 2021
https://pubmed.ncbi.nlm.nih.gov/33664680/

Naltrexone reduces pain intensity and improves life for those with chronic pain, review suggests

The Pharmaceutical Journal
15 March 2021
https://pharmaceutical-journal.com/article/news/naltrexone-reduces-pain-intensity-and-improves-life-for-those-with-chronic-pain-review-suggests

Low Dose Naltrexone Emerging as Treatment for Intractable Pain

Pain News Network
10 March 2021
https://www.painnewsnetwork.org/stories/2021/3/10/low-dose-naltrexone-emerging-as-treatment-for-intractable-pain-patients

Low-Dose Naltrexone May Be Opioid Replacement for Chronic Pain

Verywell Health
04 March 2021
https://www.verywellhealth.com/low-dose-naltrexone-may-be-opioid-replacement-for-chronic-pain-5115153

Nutrichem's LDN Book Event with Dr Adam Livingston (Low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Adam Livingston, PharmD, BSc., RPh.

Low-dose Naltrexone (LDN) Prescription Basics

What Do Primary Care Providers and Nurses Need to Know About Managing Chronic Pain?